Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosol Lung Distribution: Aeroneb Solo vs Jet Nebulizer via HFNC
NCT02429817Completed
- Start
- Apr 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Randomised, open-label trial. Primary endpoint: Pulmonary deposition at 15 months. Started Apr 2015; status: completed.
Beyond the preview
Go deeper on NCT02429817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429817.